reference/10605400

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/10605400

Outgoing Links

Predicate	Object
contentType	Journal Article\|Multicenter Study\|Randomized Controlled Trial
endingPage	1846
issn	1349-7235 0918-2918
issueIdentifier	22
pageRange	1837-1846
publicationName	Internal medicine (Tokyo, Japan)
startingPage	1837
bibliographicCitation	Derosa G, D'Angelo A, Fogari E, Salvadeo S, Gravina A, Ferrari I, Cicero AF. Effects of nateglinide and glibenclamide on prothrombotic factors in naïve type 2 diabetic patients treated with metformin: a 1-year, double-blind, randomized clinical trial. Intern Med. 2007;46(22):1837–46. doi: 10.2169/internalmedicine.46.0320. PMID: 18025765.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-9446-7546 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_32537fd933e3944bf3d441b667e7a174 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_124ec980ec8b00b6bd01e1168681fd24 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0003-3008-9264 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7e7d9ebbe99b1275bd0db3105463a3dd http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4f3f412a449fdcac7c996728e38896a6 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_33a006c5c75b888dc8800bd0a98f039b http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9f2760fbee87583b33fe3d9310688996 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0003-3573-4760 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5622367951ab805890337df7c627fc5b
date	2007
identifier	https://doi.org/10.2169/internalmedicine.46.0320 https://pubmed.ncbi.nlm.nih.gov/18025765
isPartOf	http://rdf.ncbi.nlm.nih.gov/pubchem/journal/2038 https://portal.issn.org/resource/ISSN/0918-2918 https://portal.issn.org/resource/ISSN/1349-7235
language	English
source	https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/
title	Effects of Nateglinide and Glibenclamide on Prothrombotic Factors in Naieve Type 2 Diabetic Patients Treated with Metformin: A 1-Year, Double-Blind, Randomized Clinical Trial
discusses	http://id.nlm.nih.gov/mesh/M0016991 http://id.nlm.nih.gov/mesh/M0013535 http://id.nlm.nih.gov/mesh/M0026409 http://id.nlm.nih.gov/mesh/M0016544 http://id.nlm.nih.gov/mesh/M0005469 http://id.nlm.nih.gov/mesh/M0010903 http://id.nlm.nih.gov/mesh/M0009265 http://id.nlm.nih.gov/mesh/M0353981
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D005905Q000494 http://id.nlm.nih.gov/mesh/D017395Q000097 http://id.nlm.nih.gov/mesh/D003510Q000494 http://id.nlm.nih.gov/mesh/D010649Q000031 http://id.nlm.nih.gov/mesh/D010959Q000187 http://id.nlm.nih.gov/mesh/D003924Q000188 http://id.nlm.nih.gov/mesh/D007004Q000494
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D008875 http://id.nlm.nih.gov/mesh/D000328 http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D008687Q000494 http://id.nlm.nih.gov/mesh/D004359 http://id.nlm.nih.gov/mesh/D010649Q000494 http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D004311 http://id.nlm.nih.gov/mesh/D000077715
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7444 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3488 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4091 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5311309 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID91552 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_58abb759e5602eec30e9e8ac773f9bc9 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5793 http://rdf.ncbi.nlm.nih.gov/pubchem/protein/EC_3.4.21.68 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_cdf1e220d89c2dcd2e000c3d105bf93e http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7181

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129928295 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127654813 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129765044 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128797137 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129621433 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127838534

Total number of triples: 70.